日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A 52-week open-label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

一项为期 52 周的开放标签扩展研究，旨在评估口服瑞美吉泮预防偏头痛的安全性和有效性

期刊:Headache
影响因子:4
doi:10.1111/head.15002
Kudrow, David; Croop, Robert S; Thiry, Alexandra; Lipton, Richard B
偏头痛
神经科学
发表日期：2026
文献求助 收藏

Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study

利美吉泮在患有偏头痛、焦虑症、抑郁症或正在服用抗抑郁药的成年患者中的安全性：一项多中心、长期、开放标签研究的分析

期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-024-00675-6
Kudrow, David; Hutchinson, Susan; Pixton, Glenn C; Fullerton, Terence
偏头痛
抑郁症
焦虑症
神经科学
发表日期：2025
文献求助 收藏

Oral rimegepant as a preventive treatment of migraine: a plain language summary of a clinical study

口服瑞美吉泮预防偏头痛：一项临床研究的简明摘要

期刊:Pain Management
影响因子:1.5
doi:10.1080/17581869.2025.2522640
Croop, Robert; Lipton, Richard B; Kudrow, David; Kamen, Lisa; Conway, Charles M; Goadsby, Peter J
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

更正：弗瑞马珠单抗治疗≥60岁发作性或慢性偏头痛临床试验参与者的疗效和安全性：3项随机、双盲、安慰剂对照3期研究的汇总结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-022-01423-x
Nahas, Stephanie J; Naegel, Steffen; Cohen, Joshua M; Ning, Xiaoping; Janka, Lindsay; Campos, Verena Ramirez; Krasenbaum, Lynda J; Holle-Lee, Dagny; Kudrow, David; Lampl, Christian
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

依普汀单抗治疗慢性偏头痛患者后，偏头痛相关负担减轻

期刊:Cephalalgia
影响因子:4.6
doi:10.1177/03331024221089567
McAllister, Peter; Kudrow, David; Cady, Roger; Hirman, Joe; Ettrup, Anders
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

弗瑞马珠单抗治疗≥60岁发作性或慢性偏头痛临床试验参与者的疗效和安全性：3项随机、双盲、安慰剂对照3期研究的汇总结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01351-2
Nahas, Stephanie J; Naegel, Steffen; Cohen, Joshua M; Ning, Xiaoping; Janka, Lindsay; Campos, Verena Ramirez; Krasenbaum, Lynda J; Holle-Lee, Dagny; Kudrow, David; Lampl, Christian
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

使用erenumab治疗后，慢性偏头痛逆转为发作性偏头痛：一项随机、12周、双盲研究和一项52周开放标签扩展研究的事后分析结果

期刊:Cephalalgia
影响因子:4.6
doi:10.1177/0333102420973994
Lipton, Richard B; Tepper, Stewart J; Silberstein, Stephen D; Kudrow, David; Ashina, Messoud; Reuter, Uwe; Dodick, David W; Zhang, Feng; Rippon, Gregory A; Cheng, Sunfa; Mikol, Daniel D
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

糖尿病周围神经病变的基因治疗：一项随机、安慰剂对照的III期临床研究，评估VM202（一种编码人肝细胞生长因子的质粒DNA）的疗效。

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12977
Kessler, John A; Shaibani, Aziz; Sang, Christine N; Christiansen, Mark; Kudrow, David; Vinik, Aaron; Shin, Nari
糖尿病
细胞生物学
基因治疗
代谢
发表日期：2021
文献求助 收藏

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

Galcanezumab 对总疼痛负担的影响：一项针对发作性丛集性头痛患者的 3 期随机、双盲、安慰剂对照研究的事后分析

期刊:Journal of Pain Research
影响因子:2.5
doi:10.2147/JPR.S305066
Andrews, J Scott; Kudrow, David; Rettiganti, Mallikarjuna; Oakes, Tina; Bardos, Jennifer N; Wenzel, Richard; Kuruppu, Dulanji K; Gaul, Charly; Martinez, James M
发表日期：2021
文献求助 收藏

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

eptinezumab治疗慢性偏头痛患者的长期安全性和耐受性：一项为期2年的开放标签3期试验

期刊:BMC Neurology
影响因子:2.2
doi:10.1186/s12883-021-02123-w
Kudrow, David; Cady, Roger K; Allan, Brent; Pederson, Susan M; Hirman, Joe; Mehta, Lahar R; Schaeffler, Barbara A
偏头痛
神经科学
发表日期：2021
文献求助 收藏